{
  "docId": "019dd923-5ddf-7308-8fca-0e5cf0e1ad99",
  "docSlug": "66e1021b86be5625",
  "documentTitle": "Global pharma winners – focus and efficiency matter",
  "authorId": "RolandBerger",
  "authorName": "Roland Berger",
  "documentKindSlug": "consulting-deck",
  "documentKindLabel": "Consulting deck",
  "sourceTypeSlug": "strategy_consulting",
  "sourceTypeLabel": "Strategy consulting",
  "presentationDate": null,
  "orientation": "portrait",
  "aspectRatio": 0.707,
  "pageNumber": 5,
  "pageCount": 11,
  "prevPage": 4,
  "nextPage": 6,
  "slideType": "diagnosis",
  "function": "diagnose",
  "density": "overcrowded",
  "nDataPoints": 40,
  "notes": "The slide uses a stacked bar chart to segment companies into four performance archetypes across various industry sub-sectors.",
  "elementsJson": [
    "headline_text",
    "bar_chart_stacked",
    "data_table",
    "paragraph",
    "footnote"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-5ddf-7308-8fca-0e5cf0e1ad99/5",
  "deckHref": "/decks/019dd923-5ddf-7308-8fca-0e5cf0e1ad99",
  "deckJsonHref": "/decks/019dd923-5ddf-7308-8fca-0e5cf0e1ad99.json",
  "deckAnchorHref": "/decks/019dd923-5ddf-7308-8fca-0e5cf0e1ad99#slide-5",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "Blood plasma, CMO/CDMOs and traditional biotechs stand out 2019–2022.",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd951-e58d-7080-a16b-abcc8818abdd",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.35,
        "w": 0.43,
        "x": 0.535,
        "y": 0.15
      },
      "kind": "chart",
      "text": "Stacked bar chart showing performance archetypes by segment",
      "attrs": null,
      "subkind": "bar-stacked-100pct",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "bce8d204-c927-41f4-b5de-f91ab2e18e68",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.39,
        "x": 0.1,
        "y": 0.56
      },
      "kind": "list",
      "text": "1. Winners, 2. Value generators, 3. Profitless growers, 4. Underperformers",
      "attrs": null,
      "subkind": "numbered",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "61cc7209-f19d-4691-b650-5007988d0d7d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "metric",
      "text": "Share of winners: 67%",
      "attrs": null,
      "subkind": "primary",
      "toolName": "Quantification",
      "toolSlug": "quantification",
      "confidence": null,
      "componentId": "019dd951-e58d-7080-a16b-ae5ade006b27",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.35,
        "w": 0.35,
        "x": 0.608,
        "y": 0.58
      },
      "kind": "paragraph",
      "text": "While small molecule drug companies and consumer-health companies on average recorded the lowest share of winners between 2019 and 2022...",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4236c319-f248-4f92-ba2f-64a3a9d53967",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.39,
        "x": 0.1,
        "y": 0.095
      },
      "kind": "paragraph",
      "text": "Our Winners Analysis is a diagnostic tool for understanding a company's past performance as a blueprint for future strategy.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9e0865d1-9415-46e1-addc-f5d638667ff3",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.2,
        "x": 0.535,
        "y": 0.5
      },
      "kind": "source-note",
      "text": "*) Excluding one extreme outlier. Source: Roland Berger, Capital IQ",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f377ca16-5b87-49bd-9934-1912c5391ec9",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.4,
        "x": 0.535,
        "y": 0.115
      },
      "kind": "title",
      "text": "Blood plasma, CMO/CDMOs and traditional biotechs stand out 2019–2022",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "10121120-1d19-4ad1-8966-2c38ced2c185",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.4,
        "x": 0.535,
        "y": 0.095
      },
      "kind": "title",
      "text": "D / Three segments have highest share of winners",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ecb57bd6-ce0c-4880-bed6-6dc080d5f1ae",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "diagnostic-test",
      "slug": null,
      "matchId": "f46ed87e-89c6-4ab4-ab5e-85c72c0bd0f7",
      "evidence": "Winners Analysis diagnostic tool",
      "confidence": 0.8
    }
  ],
  "arcBeats": [
    {
      "to": 6,
      "from": 5,
      "beatId": "6c199ca9-8d4d-47cb-b8c0-49f3ad8ac907",
      "arcName": "The Consultant's Gambit",
      "arcSlug": "consultants-gambit",
      "beatName": "Evidence & Proof",
      "beatSlug": "consultants-gambit-evidence-proof",
      "evidence": "The diagnosis and key takeaways provide evidence and proof of the problems and complications",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Evidence",
      "parentBeatSlug": "evidence"
    }
  ],
  "loops": [
    {
      "to": 10,
      "from": 3,
      "name": "Logic Chain",
      "slug": "01-logic-chain",
      "bestFor": "Skeptical audiences, controversial recommendations, rigorous analysis",
      "matchId": "90ec7d40-8102-4183-9181-4f6898343bb0",
      "evidence": "The document provides a clear and logical structure, connecting the situation and context to the solution and approach",
      "position": 0,
      "objective": "To demonstrate the logic and reasoning behind the efficiency measures",
      "structure": "Premise 1 (Accepted truth) -> Premise 2 (Observed fact) -> Therefore... (Inevitable conclusion)",
      "confidence": 0.6,
      "description": "Build an airtight chain of logic where each premise leads inevitably to the conclusion"
    },
    {
      "to": 9,
      "from": 4,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "af7803fc-7fff-46d4-876f-a01233f27297",
      "evidence": "The document emphasizes the importance of efficiency measures in driving strong investor returns",
      "position": 1,
      "objective": "To highlight the cost of inaction and the importance of efficiency measures",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.6,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}